Leslie V. Farland , William J. Degnan III , Holly R. Harris , Naoko Sasamoto , Kathryn M. Rexrode , Stacey A. Missmer
{"title":"在护士健康研究II的参与者中,腹腔镜确认子宫内膜异位症和中年血浆炎症标志物、胆固醇和脂肪因子","authors":"Leslie V. Farland , William J. Degnan III , Holly R. Harris , Naoko Sasamoto , Kathryn M. Rexrode , Stacey A. Missmer","doi":"10.1016/j.maturitas.2025.108663","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Endometriosis may increase the risk of cardiovascular disease, possibly through a detrimental impact on circulating biomarkers. However, there is a paucity of research on endometriosis and inflammation, lipids, and adipokines at midlife.</div></div><div><h3>Methods</h3><div>We used generalized linear models to determine the association between laparoscopically confirmed endometriosis and log-transformed levels of plasma C-reactive protein (<em>n</em> = 3936), interleukin-6 (<em>n</em> = 3495), tumor necrosis factor-alpha receptor 2 (<em>n</em> = 2967), high-density lipoprotein cholesterol (<em>n</em> = 1533), low-density lipoprotein cholesterol (<em>n</em> = 1324), total cholesterol (<em>n</em> = 4898), leptin (<em>n</em> = 2480), and adiponectin (<em>n</em> = 4262) among participants with existing biomarker measurements in the Nurses' Health Study II (average age 44 years). We investigated heterogeneity by body mass index (<25 kg/m<sup>2</sup> vs. ≥ 25 kg/m<sup>2</sup>).</div></div><div><h3>Results</h3><div>We did not observe associations between endometriosis and midlife inflammatory biomarkers (C-reactive protein % difference: -4.6, 95 % CI [−15.7,7.9]; interleukin-6: −0.4 % [−7.2,7.1]; tumor necrosis factor-alpha receptor 2: −1.3 % [−4.1,1.6]) or levels of high-density lipoprotein cholesterol (0.8 % [−3.7,5.6]), low-density lipoprotein cholesterol (−0.2 % [−5.2,5.1]), total cholesterol (1.0 % [−0.7,2.7]), or adiponectin (−4.0 [−8.8,1.0]). Women with endometriosis had higher leptin levels (9.0 % [0.5, 18.1]). Associations varied by body mass index for total cholesterol (<em>p</em>-value 0.05) and leptin (p-value 0.02). Among women with a body mass index ≥25 kg/m<sup>2</sup>, those with endometriosis had a mean total cholesterol level that was 2.7 % higher (0.2,5.2) than among those without; among those with a body mass index <25 kg/m<sup>2</sup>, those with endometriosis had a mean leptin level that was 15.7 % higher (4.6, 28.1) than among those without endometriosis.</div></div><div><h3>Conclusions</h3><div>Endometriosis was not associated with midlife systemic inflammation, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, or adiponectin. Endometriosis was associated with higher leptin among those with a body mass index <25 kg/m<sup>2</sup> and higher total cholesterol among those with a body mass index ≥25 kg/m<sup>2</sup>. These findings suggest that endometriosis may influence cardiovascular disease risk via midlife cholesterol and leptin.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"200 ","pages":"Article 108663"},"PeriodicalIF":3.9000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Laparoscopically confirmed endometriosis and midlife plasma markers of inflammation, cholesterol, and adipokines among participants in the Nurses' Health Study II\",\"authors\":\"Leslie V. Farland , William J. Degnan III , Holly R. Harris , Naoko Sasamoto , Kathryn M. Rexrode , Stacey A. Missmer\",\"doi\":\"10.1016/j.maturitas.2025.108663\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Endometriosis may increase the risk of cardiovascular disease, possibly through a detrimental impact on circulating biomarkers. However, there is a paucity of research on endometriosis and inflammation, lipids, and adipokines at midlife.</div></div><div><h3>Methods</h3><div>We used generalized linear models to determine the association between laparoscopically confirmed endometriosis and log-transformed levels of plasma C-reactive protein (<em>n</em> = 3936), interleukin-6 (<em>n</em> = 3495), tumor necrosis factor-alpha receptor 2 (<em>n</em> = 2967), high-density lipoprotein cholesterol (<em>n</em> = 1533), low-density lipoprotein cholesterol (<em>n</em> = 1324), total cholesterol (<em>n</em> = 4898), leptin (<em>n</em> = 2480), and adiponectin (<em>n</em> = 4262) among participants with existing biomarker measurements in the Nurses' Health Study II (average age 44 years). We investigated heterogeneity by body mass index (<25 kg/m<sup>2</sup> vs. ≥ 25 kg/m<sup>2</sup>).</div></div><div><h3>Results</h3><div>We did not observe associations between endometriosis and midlife inflammatory biomarkers (C-reactive protein % difference: -4.6, 95 % CI [−15.7,7.9]; interleukin-6: −0.4 % [−7.2,7.1]; tumor necrosis factor-alpha receptor 2: −1.3 % [−4.1,1.6]) or levels of high-density lipoprotein cholesterol (0.8 % [−3.7,5.6]), low-density lipoprotein cholesterol (−0.2 % [−5.2,5.1]), total cholesterol (1.0 % [−0.7,2.7]), or adiponectin (−4.0 [−8.8,1.0]). Women with endometriosis had higher leptin levels (9.0 % [0.5, 18.1]). Associations varied by body mass index for total cholesterol (<em>p</em>-value 0.05) and leptin (p-value 0.02). Among women with a body mass index ≥25 kg/m<sup>2</sup>, those with endometriosis had a mean total cholesterol level that was 2.7 % higher (0.2,5.2) than among those without; among those with a body mass index <25 kg/m<sup>2</sup>, those with endometriosis had a mean leptin level that was 15.7 % higher (4.6, 28.1) than among those without endometriosis.</div></div><div><h3>Conclusions</h3><div>Endometriosis was not associated with midlife systemic inflammation, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, or adiponectin. Endometriosis was associated with higher leptin among those with a body mass index <25 kg/m<sup>2</sup> and higher total cholesterol among those with a body mass index ≥25 kg/m<sup>2</sup>. These findings suggest that endometriosis may influence cardiovascular disease risk via midlife cholesterol and leptin.</div></div>\",\"PeriodicalId\":51120,\"journal\":{\"name\":\"Maturitas\",\"volume\":\"200 \",\"pages\":\"Article 108663\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maturitas\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378512225004712\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maturitas","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378512225004712","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Laparoscopically confirmed endometriosis and midlife plasma markers of inflammation, cholesterol, and adipokines among participants in the Nurses' Health Study II
Objective
Endometriosis may increase the risk of cardiovascular disease, possibly through a detrimental impact on circulating biomarkers. However, there is a paucity of research on endometriosis and inflammation, lipids, and adipokines at midlife.
Methods
We used generalized linear models to determine the association between laparoscopically confirmed endometriosis and log-transformed levels of plasma C-reactive protein (n = 3936), interleukin-6 (n = 3495), tumor necrosis factor-alpha receptor 2 (n = 2967), high-density lipoprotein cholesterol (n = 1533), low-density lipoprotein cholesterol (n = 1324), total cholesterol (n = 4898), leptin (n = 2480), and adiponectin (n = 4262) among participants with existing biomarker measurements in the Nurses' Health Study II (average age 44 years). We investigated heterogeneity by body mass index (<25 kg/m2 vs. ≥ 25 kg/m2).
Results
We did not observe associations between endometriosis and midlife inflammatory biomarkers (C-reactive protein % difference: -4.6, 95 % CI [−15.7,7.9]; interleukin-6: −0.4 % [−7.2,7.1]; tumor necrosis factor-alpha receptor 2: −1.3 % [−4.1,1.6]) or levels of high-density lipoprotein cholesterol (0.8 % [−3.7,5.6]), low-density lipoprotein cholesterol (−0.2 % [−5.2,5.1]), total cholesterol (1.0 % [−0.7,2.7]), or adiponectin (−4.0 [−8.8,1.0]). Women with endometriosis had higher leptin levels (9.0 % [0.5, 18.1]). Associations varied by body mass index for total cholesterol (p-value 0.05) and leptin (p-value 0.02). Among women with a body mass index ≥25 kg/m2, those with endometriosis had a mean total cholesterol level that was 2.7 % higher (0.2,5.2) than among those without; among those with a body mass index <25 kg/m2, those with endometriosis had a mean leptin level that was 15.7 % higher (4.6, 28.1) than among those without endometriosis.
Conclusions
Endometriosis was not associated with midlife systemic inflammation, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, or adiponectin. Endometriosis was associated with higher leptin among those with a body mass index <25 kg/m2 and higher total cholesterol among those with a body mass index ≥25 kg/m2. These findings suggest that endometriosis may influence cardiovascular disease risk via midlife cholesterol and leptin.
期刊介绍:
Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond publishing original research, reviews, consensus statements and guidelines, and mini-reviews. The journal provides a forum for all aspects of postreproductive health in both genders ranging from basic science to health and social care.
Topic areas include:• Aging• Alternative and Complementary medicines• Arthritis and Bone Health• Cancer• Cardiovascular Health• Cognitive and Physical Functioning• Epidemiology, health and social care• Gynecology/ Reproductive Endocrinology• Nutrition/ Obesity Diabetes/ Metabolic Syndrome• Menopause, Ovarian Aging• Mental Health• Pharmacology• Sexuality• Quality of Life